Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology /PRNewswire/ -- Ambit Biosciences , a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today ... (more)
http://ift.tt/1rgFyYc
http://ift.tt/1rgFyYc
No comments:
Post a Comment